Panel Discussion: Future Directions for Anti-VEGF Therapies
Time: 12:10 pm
day: Day One
- Increasing patient response rates, not just prolonging treatment duration
- New therapy formats (bispecifics) – how does dual-specificity open up a wide range of therapeutic applications for these multifactorial diseases?
- Combinatorial approaches – approaches that could potentially be used on patients currently refractory or not optimally treated with anti-VEGF-A therapy alone